Biodexa (BDRX): Prakiraan wutah bathi kanggo taun ngarep

Efficient delivery of oncology drugs to medical centers ensures stable patient access to therapy. The forward earnings per share growth forecast visualizes the consensus reaction to market shocks, where 0.00 determines the current status of the parameter. Transparent R&D control by specialized management and the humanitarian status of the sector, which eliminates geopolitical risks, create a sustainable foundation for the development of Biodexa Pharmaceuticals (BDRX).

BDRX: Prakiraan wutah bathi resik saben saham ing taun ngarep Biodexa Pharmaceuticals 28.04.2023 - 15.11.2026

Rincian analitis lan laporan data perusahaan Biodexa Pharmaceuticals (BDRX)

- rega lan prakiraan konsensus rega:

Bagan rega Biodexa|BDRX - Rata-rata rega prakiraan

- data kapitalisasi bursa:

Kapitalisasi pasar BDRX|BDRX - Nilai Bisnis

- indikator kapitalisasi buku:

Nilai Buku saben Saham Biodexa Pharmaceuticals|BDRX - Ekuitas Perusahaan|Rasio Kapitalisasi marang Aset Bersih biodexapharma.com|BDRX - Total Aset Bisnis

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal Biodexa Pharmaceuticals|BDRX - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas biodexapharma.com|BDRX - Kewajiban utang agregat|Rasio utang marang kapitalisasi buku Biodexa Pharmaceuticals PLC|BDRX - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Biodexa Pharmaceuticals|Rasio cepet biodexapharma.com

- informasi bathi lan kelipatan valuasi:

BDRX - Bathi resik|Bathi sing dikarepake Biodexa Pharmaceuticals|BDRX - Nilai perusahaan marang bathi resik|Rega marang bathi mangsa ngarep biodexapharma.com|BDRX - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Biodexa Pharmaceuticals PLC|BDRX - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) Biodexa Pharmaceuticals|BDRX - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan biodexapharma.com|BDRX - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Biodexa Pharmaceuticals

- data total pendapatan lan volume dodolan:

BDRX - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan Biodexa|BDRX - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S BDRX|BDRX - Wutah pendapatan taunan sajrone rolas wulan kepungkur

Pambiji fundamental perusahaan:BDRX, biodexapharma.com

Biodexa Pharmaceuticals maintains stability within the targeted therapy niche for rare oncological diseases through orphan drug designations, rendering the next year's EPS growth target a key indicator of margin protection efficiency. This metric measures the expected change in earnings per share, allowing investors to assess cash flow sustainability and the risk of inflated market expectations regarding future revenues.

Karo sapa Biodexa Pharmaceuticals saingan

Prakiraan wutah bathi saben saham kanggo taun ngarep CVS|Prakiraan wutah bathi resik saben saham ing taun ngarep mckesson.com MCK|Prakiraan wutah bathi resik saben saham kanggo taun ngarep AmerisourceBergen Corporation (COR)|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Cardinal Health Inc|henryschein.com - Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep Prestige Consumer Healthcare Inc (PBH)|Wellgistics Health, Inc. - Prakiraan wutah bathi kanggo taun ngarep|YI - Prakiraan wutah bathi kanggo taun ngarep|China Jo-Jo Drugstores, Inc (RDGT) - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Universe Pharmacy (UPC)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Hong Kong Pharma Digital Limited|Prakiraan wutah bathi resik saben saham kanggo taun ngarep BIMI|Prakiraan wutah bathi saben saham kanggo taun ngarep CJJD (China Jo-Jo Drugstores, Inc.)|WBA (Walgreens Boots Alliance, Inc.) - Dinamika bathi saben saham sing diarepake ing taun ngarep